Protease inhibitors and the new AIDS combination therapies: Implications for psychological services

被引:32
作者
Kalichman, SC
Ramachandran, B
Ostrow, D
机构
[1] Med Coll Wisconsin, Ctr AIDS Intervent Res, Milwaukee, WI 53226 USA
[2] Georgia State Univ, Atlanta, GA 30303 USA
[3] Howard Brown Hlth Clin, Chicago, IL USA
关键词
D O I
10.1037/0735-7028.29.4.349
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Practicing psychologists face many challenges in caring for people living with HIV infection, including keeping abreast of new treatments and their impact on the psyche. Highly active antiretroviral therapies, which include protease inhibitors, demand particularly strict adherence to cumbersome treatment regimens, potentially interact with psychotropic medications, are not universally accessible, and may lower vigilance against AIDS. The promises of new treatments are also not always realized, and treatment failures pose significant psychological ramifications. In keeping pace with the ever-changing AIDS epidemic, psychologists and counselors should be aware of the promises and the realities of advances in medical treatments for HIV infection.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 46 条
[1]   Psychosocial aspects of antiretroviral medication use among HIV patients [J].
Aversa, SL ;
Kimberlin, C .
PATIENT EDUCATION AND COUNSELING, 1996, 29 (02) :207-219
[2]   Protease inhibitors in the homeless [J].
Bangsberg, D ;
Tulsky, JP ;
Hecht, FM ;
Moss, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :63-65
[3]  
BARTLETT JG, 1993, J HOPKINS HOSPITAL G
[4]   COMPLIANCE IN CLINICAL-TRIALS [J].
BESCH, CL .
AIDS, 1995, 9 (01) :1-10
[5]  
CHUCK S, IN PRESS BEHAV MENTA
[6]   AIDS - Advances painted in shades of gray at a DC conference [J].
Cohen, J .
SCIENCE, 1997, 275 (5300) :615-616
[7]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[8]   HIV-1 protease inhibitors - A review for clinicians [J].
Deeks, SG ;
Smith, M ;
Holodniy, M ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153
[9]   Are advances in treatment changing views about high-risk sex? [J].
Dilley, JW ;
Woods, WJ ;
McFarland, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :501-502
[10]   Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients [J].
Fatkenheuer, G ;
Theisen, A ;
Rockstroh, J ;
Grabow, T ;
Wicke, C ;
Becker, K ;
Wieland, U ;
Pfister, H ;
Reiser, M ;
Hegener, P ;
Franzen, C ;
Schwenk, A ;
Salzberger, B .
AIDS, 1997, 11 (14) :F113-F116